Intensity modulated conformal radiotherapy of a jugulo-tympanic paraganglioma
Department of radiation oncology, University hospital Hassan II, Fez, Morocco.
Case Study
World Journal of Advanced Research and Reviews, 2021, 12(03), 349–353
Article DOI: 10.30574/wjarr.2021.12.3.0711
Publication history:
Received on 15 November 2021; revised on 22 December 2021; accepted on 24 December 2021
Abstract:
Jugulo-tympanic paragangliomas are rare benign tumors arising from the neuroectodermal cells of the tympanic cavity and the dome of the jugular vein. Surgical resection has long been the first-line treatment. However, when this is not possible, radiotherapy remains a therapeutic alternative allowing local control with less morbidity. We report the case of a patient with an unresectable tympano-jugular paraganglioma, the symptomalagy was dominted by chronic headaches and right sided hypoacousie, and the treatment consisted of external radiation therapy with a total dose of 50 Gy in 25 fractions, one fraction per day, 2 Gy per fraction using the IMRT technique. The evolution was good with disappearance of clinical symptomatology, significant local control with less toxicity.
Keywords:
Jugulo-tympanic; Paraganglioma; IMRT; Radiotheray
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0